As AI capabilities advance, companies are preparing for a shift toward self-improving systems, raising concerns around ...
AI companies are increasingly worried that autonomous systems could improve themselves faster than humans can safely monitor ...
Key factors driving this growth include the increasing need to lower drug development costs and timelines, the rising ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results